What is the recommended dose of acyclovir (antiviral medication) for treating herpes zoster?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Dosing for Herpes Zoster

For herpes zoster (shingles), the recommended dose is acyclovir 800 mg orally 5 times daily for 7-10 days, initiated within 72 hours of rash onset for maximum benefit. 1, 2, 3

Oral Therapy Regimen

Standard Dosing

  • Acyclovir 800 mg orally 5 times daily for 7-10 days is the established regimen for immunocompetent adults with herpes zoster 1, 2, 3
  • The 800 mg dose is superior to lower doses (400 mg showed no significant benefit over placebo) 3
  • Treatment must be started within 72 hours of rash onset; starting after 48 hours significantly reduces efficacy 2

Clinical Benefits of Treatment

  • Accelerates resolution of rash with faster time to crusting and healing 1, 2, 3
  • Reduces duration and severity of acute pain during the first 2-10 days of treatment 2, 3
  • Decreases new lesion formation and prevents dissemination to adjacent dermatomes 1, 3
  • May reduce the prevalence of post-herpetic neuralgia in the first 3 months, though this benefit is modest 1, 3

Intravenous Therapy for Severe Disease

When to Use IV Acyclovir

  • For severe disease, complications, or hospitalized patients: acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical improvement 4
  • IV therapy is indicated for immunocompromised patients, disseminated zoster, or CNS involvement 5
  • The higher dose (10 mg/kg) is preferred given that varicella-zoster virus is less sensitive to acyclovir than herpes simplex virus 5

Critical Safety Considerations with IV Therapy

  • Maintain adequate hydration and urine flow to prevent crystalluria 5
  • Monitor mental status as neurotoxicity can occur 5
  • Adjust dosing downward in renal impairment 5

Alternative Agent: Valacyclovir

  • Valacyclovir 1000 mg orally 3 times daily for 7 days offers superior convenience with equivalent or better efficacy compared to acyclovir 6
  • Valacyclovir provides 3-5 fold higher bioavailability than acyclovir, allowing less frequent dosing 6
  • It significantly accelerates resolution of pain (median 38 days vs 51 days with acyclovir) and reduces post-herpetic neuralgia duration 6

Special Populations

Immunocompromised Patients

  • Require more aggressive therapy with higher doses or IV administration 7, 4
  • May need suppressive therapy with acyclovir 400 mg orally 3-5 times daily 4
  • Higher risk of acyclovir-resistant strains, which require foscarnet 40 mg/kg IV 3 times daily or 60 mg/kg IV twice daily 4

Common Pitfalls to Avoid

  • Never use topical acyclovir for herpes zoster—it is substantially less effective than oral therapy 7
  • Do not delay treatment beyond 72 hours of rash onset, as efficacy drops significantly 2
  • The 400 mg dose is inadequate for herpes zoster (unlike herpes simplex) and should not be used 3
  • Acyclovir does not eradicate latent virus and does not prevent future recurrences 7

References

Research

Efficacy of oral acyclovir treatment of acute herpes zoster.

The American journal of medicine, 1988

Research

Therapy of herpes zoster with oral acyclovir.

The American journal of medicine, 1988

Guideline

Aciclovir Dosage for HSV and VZV Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antiviral treatment in chickenpox and herpes zoster.

Journal of the American Academy of Dermatology, 1988

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.